University of California, Merced

Total Page:16

File Type:pdf, Size:1020Kb

University of California, Merced UNIVERSITY OF CALIFORNIA, MERCED SUMOylation is a regulator of regional cell fate and genomic integrity in planarians by Manish Thiruvalluvan A dissertation submitted in satisfaction of the requirements for the degree Doctor of Philosophy in Quantitative and Systems Biology Committee in Charge: Professor Kirk Jensen, Chair Professor Jennifer Manilay, Member Professor Anna Beaudin, Member Professor Néstor J. Oviedo, Advisor 2018 i Copyright Manish Thiruvalluvan, 2018 All rights reserved ii The dissertation of Manish Thiruvalluvan is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Jennifer Manilay Anna Beaudin Kirk Jensen, Chair University of California, Merced 2018 iii TABLE OF CONTENTS vi. List of figures vii. List of abbreviations viii. Acknowledgements ix. Curriculum vitae xii. Abstract 1. Introduction 1.1. Regional signals influence cell fate decisions in health and disease 1.2. SUMOylation – a type of posttranslational modification 1.3. The planarian model Schmidtea mediterranea 1.4. Research summary 2. Materials and Methods 2.1. Materials 2.1.1. Organisms 2.1.2. Selection of primers and cloning 2.1.3. Antibodies, enzymes and other reagents 2.1.4. Solutions and buffers 2.2. Methods 2.2.1. Planarian husbandry 2.2.2. Identification of orthologs and phylogenetic analysis 2.2.3. PCR amplification and gel electrophoresis 2.2.4. Planarian Amputation 2.2.5. Irradiation 2.2.6. RNAi by bacteria feeding 2.2.7. Fixation protocols 2.2.8. RNA extraction 2.2.9. Planarian cell dissociation 2.2.10. Immunocytochemistry 2.2.11. RNA probe synthesis 2.2.12. In situ hybridization 2.2.13. Quantitative PCR (qPCR) 2.2.14. Protein extraction and Western blot 2.2.15. COMET assay 2.2.16. Flow cytometry 2.2.17. Karyotyping 2.2.18. Planarian datamining 2.2.19. Imaging and data processing 2.2.20. Statistical analysis iv 2.2.21. RNA Sequencing and Differential Expression Analysis 3. Results 3.1. SUMO pathway genes are conserved in the planarian Schmidtea mediterranea 3.2. UBC9 is required for regional tissue maintenance 3.3. UBC9 is actively expressed by the stem cell compartment 3.4. UBC9 is required for proper stem cell function and cell cycle transition 3.5. UBC9 is necessary for maintenance of neoblasts and postmitotic cells 3.6. Downregulation of SUMO pathway components recapitulates UBC9 RNAi phenotype 3.7. UBC9 knockdown leads to regional increase in cell death 3.8. Regional defects after UBC9 RNAi are mediated through repression of Hedgehog signaling pathway 3.9. Loss of UBC9 leads to defects in regeneration and attenuation of the cephalic ganglia 3.10. UBC9 is required for maintenance of genomic integrity 3.11. UBC9 facilitates nuclear transport of RAD51 to repair double stranded breaks 3.12. RNA Sequencing reveals MADD as a novel regulator of neoblast function 3.13. Knockdown of MADD rescues UBC9 phenotype by reducing cell death in the posterior 4. Discussion 4.1. SUMOylation is required for proper cell function and tissue homeostasis in planarians 4.2. A novel role for UBC9 and SUMOylation in regeneration 4.3. UBC9 and RAD51 knockdown models to study genomic instability and cancer 4.4. Rescue of UBC9 phenotype by MADD highlights long-range neural control of cell fate 4.5. Final remarks and future direction 5. References v LIST OF FIGURES 1. Figure 1: SUMOylation and the planarian model Schmidtea mediterranea 2. Figure 2: The SUMOylation pathway is conserved in the planarian model Schmidtea mediterranea 3. Figure 3: UBC9 is required for regional tissue maintenance 4. Figure 4: UBC9 is actively expressed by the stem cell compartment 5. Figure 5: UBC9 is required for neoblast proliferation 6. Figure 6: UBC9 is responsible for proper cell cycle transition 7. Figure 7: UBC9 is necessary for maintenance of proliferative and post- mitotic cells 8. Figure 8: Downregulation of SUMO pathway components recapitulates UBC9 RNAi phenotype 9. Figure 9: UBC9 knockdown leads to regional increase in cell death 10. Figure 10: Planarian posterior polarity is maintained by the Hedgehog signaling pathway 11. Figure 11: Regional defects after UBC9 RNAi after partially mediated through a repression of Hedgehog signaling 12. Figure 12: UBC9 is required for proper regeneration 13. Figure 13: Double knockdown of Patched and UBC9 eliminates blastema formation 14. Figure 14: UBC9 is required to maintain genomic integrity along the anteroposterior axis 15. Figure 15: UBC9 facilitates nuclear transport of RAD51 to repair double stranded breaks 16. Figure 16: UBC9 and RAD51 work synergistically to maintain tissue homeostasis 17. Figure 17: Transcriptomic analysis of UBC9 knockdown model identifies MADD as a potential regulator of neoblast function 18. Figure 18: MADD regulates fissioning behavior and neoblast maintenance 19. Figure 19: MADD knockdown rescues UBC9 RNAi abnormalities by ablating cell death in the posterior region 20. Figure 20: RAD51 and UBC9 knockdown yields high levels of DNA damage, but different neoblast responses 21. Figure 21: Schematic summary representing Smed UBC9 acts as an upstream regulator of different functions in the adult body vi LIST OF ABBREVIATIONS 1. Smed – Schmidtea mediterranea 2. DSB – double stranded breaks 3. SUMO pathway – includes the entire signaling pathway, including the SUMO enzymes 4. SUMO - small-ubiquitin like modifier 5. DDR – DNA damage repair 6. DSBs – double stranded breaks 7. ASCs – Adult stem cells 8. SENP – sentrin specific protease 9. SAE1/2 – SUMO activating enzyme subunit 1/2 10. Hh – Hedgehog 11. Ptc – Patched 12. Smo -Smoothened 13. Sfrp1 – secreted frizzled like protein 1 14. Fz4 – frizzled like protein 1 15. AP axis - anteroposterior axis 16. DNA damage and repair – DDR 17. ROS – reactive oxygen species 18. D. melanogaster – drosophila melanogaster 19. C. elegans - Caenorhabditis elegans 20. BRCA1 – breast cancer associated 1 21. XRCC4 - X-ray repair cross-complementing protein 4 22. Ku70 - Lupus Ku autoantigen protein p70 23. ATM - ATM serine/threonine kinase 24. ATR - ataxia telangiectasia and Rad3 related 25. RANGAP1 - Ran GTPase Activating Protein 1 26. RanBP2 - RAN Binding Protein 2 27. PIAS - protein inhibitor of activated STAT 28. H2Ax - H2A histone family, member X 29. PTEN - Phosphatase and tensin homolog 30. COMET - single cell gel electrophoresis 31. MADD - MAP kinase activating death domain 32. Rb – retinoblastoma protein 33. p53 – tumor protein p53 vii ACKNOWLEDGEMENTS First, I want to thank Dr. Nestor Oviedo for believing in me ever since he took me in as an undergraduate and encouraged me to get my PhD when all other paths were closed. He has helped me not only becoming a better scientist, but a better teacher and a better person. I greatly enjoyed my time working with him and sincerely appreciate everything he has done for me. In the same vein, I would like to thank all members of my lab, especially Paul, who has helped me immensely in carrying out experiments. It was my pleasure to work day in and day out with my colleagues who made the tedious process of bench work more enjoyable. Special thanks to Dr. David Ardell and Melanie LeGro for their work with transcriptomic analysis as this data drove the late stages of my research. I would also like to thank members of my committee, Dr. Jennifer Manilay, Dr. Anna Beaudin and Dr. Kirk Jensen, who stuck with me and helped me finish my doctoral journey. In addition, I would like to thank Dr. Limor Broday and her lab for their expertise in SUMOylation and for helping bring forth and develop this idea into a successful project. I am extremely grateful to my parents for bringing me to this country and providing me with a once in a lifetime opportunity to pursue higher education. Finally, I want to thank my wife Sandra, who has been at my side for most of my adult life and has encouraged me to pursue and achieve my dreams. When I started my PhD, I was twenty-one and just graduated college. Now, I’m a husband and father to my son Alex. Without her help, I would not have been able to come this far. viii CURRICULUM VITAE Manish Thiruvalluvan Ph.D. Quantitative and Systems Biology School of Natural Sciences 5200 N Lake Rd, Merced, CA 95340 (408) 910-9028 | [email protected] I. EDUCATION 2013 – present Ph.D., Quantitative and Systems Biology, University of California Merced • Worked with the planarian model system to study stem cell proliferation and regeneration • Conceived, developed and conducted independent research directed at identifying the molecular mechanism behind differential rates of cancer formation • Identified epigenetic modifications through UBC9 and the SUMOylation is responsible for regulating regional maintenance of cell survival and DNA damage in the adult body • Presented my research at various conferences and meetings around the United States • Dissertation: Role of SUMOylation in stem cell regulation and DNA damage repair in planarians • Advisor: Nestor J. Oviedo 2009 – 2013 Bachelor of Science, Human Biology, University of California Merced (Cum Laude) • Dean's List: Awarded four times • Academic Chair of Hermanos Unidos Organization, 2011-2013 • Leadership position in Tae Kwon Do Club, 2010-2012 2007 – 2011 Stockton Delta College • Attended part time as a high school student and undergraduate • Classes Taken: Psychology, Writing, Statistics, Mythology, Music Theory and Speech II. PUBLICATIONS 1. Thiruvalluvan, M., Barghouth, P. G., Tsur, A., Broday, L., & Oviedo, N. J. (2018). SUMOylation controls stem cell proliferation and regional cell death through Hedgehog signaling in planarians. Cellular and Molecular Life Sciences: CMLS, 75(7), 1285–1301. https://doi.org/10.1007/s00018-017-2697-4 2. Barghouth, P. G., Thiruvalluvan, M., LeGro, M., & Oviedo, N. J. (2018). DNA damage and tissue repair: What we can learn from planaria. Seminars in Cell & Developmental Biology. https://doi.org/10.1016/j.semcdb.2018.04.013 ix 3.
Recommended publications
  • Análise Integrativa De Perfis Transcricionais De Pacientes Com
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Ribeirão Preto – 2012 ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de Concentração: Genética Orientador: Prof. Dr. Eduardo Antonio Donadi Co-orientador: Prof. Dr. Geraldo A. S. Passos Ribeirão Preto – 2012 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Evangelista, Adriane Feijó Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas. Ribeirão Preto, 2012 192p. Tese de Doutorado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de Concentração: Genética. Orientador: Donadi, Eduardo Antonio Co-orientador: Passos, Geraldo A. 1. Expressão gênica – microarrays 2. Análise bioinformática por module maps 3. Diabetes mellitus tipo 1 4. Diabetes mellitus tipo 2 5. Diabetes mellitus gestacional FOLHA DE APROVAÇÃO ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Progress in the Discovery of Small Molecule Modulators of Desumoylation
    Curr. Issues Mol. Biol. (2020) 35: 17-34. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation Shiyao Chen, Duoling Dong, Weixiang Xin and Huchen Zhou* School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.017 Abstract protein–protein interactions, gene transcription, SUMOylation and DeSUMOylation are reversible genome integrity, and DNA replication and repair protein post-translational modifcation (PTM) (Wilkinson and Henley, 2010; Vierstra, 2012; processes involving small ubiquitin-like modifer Bailey et al., 2016). In 1995, Meluh and Koshland (SUMO) proteins. Tese processes have indis- (1995) identifed Smt3 in Saccharomyces cerevi- pensable roles in various cellular processes, such siae, which is the earliest report within this fled. as subcellular localization, gene transcription, and Two years later, based on the sequence similarity DNA replication and repair. Over the past decade, between ubiquitin and a new 11.5-kDa protein, increasing atention has been given to SUMO- ubiquitin/SMT3, the name SUMO was formally related pathways as potential therapeutic targets. proposed for the frst time (Mahajan et al., 1997). Te Sentrin/SUMO-specifc protease (SENP), Although SUMO modifcation is closely which is responsible for deSUMOylation, has related to the progression of various diseases, such been proposed as a potential therapeutic target as cancers and cardiac disorders, it has aroused in the treatment of cancers and cardiac disorders. increasing atention as a potential therapeutic target Unfortunately, no SENP inhibitor has yet reached in recent years, especially concerning the Sentrin/ clinical trials. In this review, we focus on advances SUMO-specifc protease (SENP), which is the key in the development of SENP inhibitors in the past regulator of deSUMOylation.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • Nucleolus: a Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky
    Nucleolus: A Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky To cite this version: Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, et al.. Nucleolus: A Central Hub for Nuclear Functions. Trends in Cell Biology, Elsevier, 2019, 29 (8), pp.647-659. 10.1016/j.tcb.2019.04.003. hal-02322927 HAL Id: hal-02322927 https://hal.archives-ouvertes.fr/hal-02322927 Submitted on 18 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Nucleolus: A Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky To cite this version: Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, et al.. Nucleolus: A Central Hub for Nuclear Functions. Trends in Cell Biology, Elsevier, 2019, 29 (8), pp.647-659. 10.1016/j.tcb.2019.04.003. hal-02322927 HAL Id: hal-02322927 https://hal.archives-ouvertes.fr/hal-02322927 Submitted on 18 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not.
    [Show full text]
  • Nucleophosmin and Its Complex Network: a Possible Therapeutic Target in Hematological Diseases
    Oncogene (2011) 30, 2595–2609 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc REVIEW Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases E Colombo1,2, M Alcalay1,2 and PG Pelicci1,2 1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy and 2Dipartimento di Medicina, Chirurgia e Odontoiatria, University of Milano, Milan, Italy Nucleophosmin (NPM, also known as B23, numatrin or alternative splicing of the NPM1 transcript, have been NO38) is a ubiquitously expressed phosphoprotein belong- reported (Wang et al., 1993) (Figure 1). In the long ing to the nucleoplasmin family of chaperones. NPM is isoform, known as B23.1, exon 9 is spliced to exon 11 mainly localized in the nucleolus where it exerts many of and the coding sequence stops at exon 12, resulting in a its functions, but a proportion of the protein continuously protein of 294 residues. In the short isoform, B23.2, shuttles between the nucleus and the cytoplasm. A growing exon 9 is spliced to exon 10 that immediately contains a number of cellular proteins have been described as stop codon, and as a result, B23.2 is a truncated protein physical interactors of NPM, and consequently, NPM is of 259 residues. The prevalent form expressed in all thought to have a relevant role in diverse cellular tissues is B23.1, although the biological significance and functions, including ribosome biogenesis, centrosome physiological function of B23.2 remain largely unclear. In duplication, DNA repair and response to stress. NPM the human EST database a further transcript variant that has been implicated in the pathogenesis of several human lacks exon 8 has been identified (GenBank accession malignancies and intriguingly, it has been described both number: NM_199185).
    [Show full text]
  • ORM-Like Protein (ORMDL) – Annäherung an Die Funktion Über Die Interaktion
    ORM-like protein (ORMDL) - Annäherung an die Funktion über die Interaktion Julian Klingbeil München 2019 Aus der Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig–Maximilians–Universität München Direktor: Prof. Dr. med. Dr. sci. nat. C. Klein ORM-like protein (ORMDL) – Annäherung an die Funktion über die Interaktion Dissertation zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultät der Ludwig–Maximilians–Universität zu München vorgelegt von Julian Malte Klingbeil aus Berlin 2019 Mit Genehmigung der Medizinischen Fakultät der Universität München Berichterstatterin: Prof. Dr. Ania Muntau Mitberichterstatter: Prof. Dr. Katja Radon PD Dr. Anne Hilgendorff Prof. Dr. Jürgen Behr Prof. Dr. Ortrud Steinlein Mitbetreuung durch den promovierten Mitarbeiter: Prof. Dr. Søren Gersting Dekan: Prof. Dr. med. dent. Reinhard Hickel Tag der mündlichen Prüfung: 10.10.2019 Inhaltsverzeichnis Zusammenfassung xiii 1 Einleitung 1 1.1 Asthma bronchiale . .1 1.1.1 Epidemiologie, Pathogenese und Klassifikation . .2 1.1.2 Therapie . .4 1.1.3 Gen-Umwelt-Interaktionen und Genomweite Assoziationsstudien5 1.2 Das neue Asthma-Risikogen ORMDL . .8 1.3 Der β2-Adrenorezeptor . 11 1.4 Protein-Protein-Interaktionen . 13 1.4.1 Biolumineszenz-Resonanz-Energie-Transfer . 15 1.5 Zielsetzung der Arbeit . 18 2 Material und Methoden 19 2.1 Material . 19 2.1.1 Laborgeräte . 19 2.1.2 Allgemeine Verbrauchsmaterialien, Chemikalien und Reagenzien . 21 2.1.3 Lösungen, Reagenzien-Kits und Puffer . 26 2.1.4 Medium . 28 2.1.5 Zelllinien und Bakterienstämme . 28 2.1.6 Antikörper . 29 2.1.7 β-Sympathomimetika . 29 2.1.8 Restriktionsenzyme . 30 2.1.9 Vektoren und DNA .
    [Show full text]
  • Systematic Discovery of Endogenous Human Ribonucleoprotein Complexes
    bioRxiv preprint doi: https://doi.org/10.1101/480061; this version posted November 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Systematic discovery of endogenous human ribonucleoprotein complexes Anna L. Mallam1,2,3,§,*, Wisath Sae-Lee1,2,3, Jeffrey M. Schaub1,2,3, Fan Tu1,2,3, Anna Battenhouse1,2,3, Yu Jin Jang1, Jonghwan Kim1, Ilya J. Finkelstein1,2,3, Edward M. Marcotte1,2,3,§, Kevin Drew1,2,3,§,* 1 Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA 2 Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, TX 78712, USA 3 Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA § Correspondence: [email protected] (A.L.M.), [email protected] (E.M.M.), [email protected] (K.D.) * These authors contributed equally to this work Short title: A resource of human ribonucleoprotein complexes Summary: An exploration of human protein complexes in the presence and absence of RNA reveals endogenous ribonucleoprotein complexes ! 1! bioRxiv preprint doi: https://doi.org/10.1101/480061; this version posted November 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Ribonucleoprotein (RNP) complexes are important for many cellular functions but their prevalence has not been systematically investigated.
    [Show full text]
  • Global Screening of Sentrin-Specific Protease Family Substrates in Sumoylation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.25.964072; this version posted February 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation Yunzhi Wang, 1, 4 Xiaohui Wu,1, 4 Rui Ge,1, 4 Lei Song, 2 Kai Li, 2 Sha Tian,1 Lili Cai, 1 Mingwei Liu, 2 Wenhao Shi, 2Guoying Yu, 3 Bei Zhen, 2 Yi Wang, 2 Fuchu He, 1, 2, * Jun Qin, 1, 2, * Chen Ding1, 2, * 1State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200432, China 2State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China 3State Key Laboratory of Cell Differentiation and Regulation, College of Life Science, Henan Normal University, Xinxiang, Henan 453007 4Co-first author *Correspondence: [email protected] (C.D.); [email protected] (J.Q.); [email protected] (F.H.); Key Words 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.25.964072; this version posted February 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Posttranslational modification; SUMO; Sentrin/SUMO-specific proteases; Mass Spectrometry; Innate Immunity Abstract Post-translational modification of proteins by the addition of small ubiquitin-related modifier (SUMO) is a dynamic process, in which deSUMOylation is carried out by members of the Sentrin/SUMO-specific protease (SENP) family.
    [Show full text]
  • Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth
    ORIGINAL www.jpeds.com • THE JOURNAL OF PEDIATRICS ARTICLES Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth Joan Kaufman, PhD1,2,3, Janitza L. Montalvo-Ortiz, PhD3, Hannah Holbrook,BA4, Kerry O'Loughlin,BA4, Catherine Orr, PhD4, Catherine Kearney,MA1, Bao-Zhu Yang, PhD3, Tao Wang, PhD5,6, Hongyu Zhao, PhD5, Robert Althoff, MD, PhD4, Hugh Garavan, PhD4, Joel Gelernter,MD3,7, and James Hudziak,MD4 Objective To determine if measures of adverse childhood experiences and DNA methylation relate to indices of obesity in youth. Study design Participants were derived from a cohort of 321 8 to 15-year-old children recruited for an investi- gation examining risk and resilience and psychiatric outcomes in maltreated children. Assessments of obesity were collected as an add-on for a subset of 234 participants (56% female; 52% maltreated). Illumina arrays were used to examine whole genome epigenetic predictors of obesity in saliva DNA. For analytic purposes, the cohort ana- lyzed in the first batch comprised the discovery sample (n = 160), and the cohort analyzed in the second batch the replication sample (n = 74). Results After controlling for race, sex, age, cell heterogeneity, 3 principal components, and whole genome testing, 10 methylation sites were found to interact with adverse childhood experiences to predict cross-sectional mea- sures of body mass index, and an additional 6 sites were found to exert a main effect in predicting body mass index (P < 5.0 × 10−7, all comparisons). Eight of the methylation sites were in genes previously associated with obesity risk (eg, PCK2, CxCl10, BCAT1, HID1, PRDM16, MADD, PXDN, GALE), with several of the findings from the dis- covery data set replicated in the second cohort.
    [Show full text]
  • A Role for Alternative Splicing in Circadian Control of Exocytosis and Glucose Homeostasis
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press A role for alternative splicing in circadian control of exocytosis and glucose homeostasis Biliana Marcheva,1,5 Mark Perelis,1,2,5 Benjamin J. Weidemann,1,5 Akihiko Taguchi,1 Haopeng Lin,3 Chiaki Omura,1 Yumiko Kobayashi,1 Marsha V. Newman,1 Eugene J. Wyatt,4 Elizabeth M. McNally,4 Jocelyn E. Manning Fox,3 Heekyung Hong,1 Archana Shankar,2 Emily C. Wheeler,2 Kathryn Moynihan Ramsey,1 Patrick E. MacDonald,3 Gene W. Yeo,2 and Joseph Bass1 1Department of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA; 2Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, California 92093, USA; 3Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada; 4Center for Genetic Medicine, Northwestern University, Chicago, Illinois 60611, USA The circadian clock is encoded by a negative transcriptional feedback loop that coordinates physiology and behavior through molecular programs that remain incompletely understood. Here, we reveal rhythmic genome-wide alter- native splicing (AS) of pre-mRNAs encoding regulators of peptidergic secretion within pancreatic β cells that are − − − − perturbed in Clock / and Bmal1 / β-cell lines. We show that the RNA-binding protein THRAP3 (thyroid hormone receptor-associated protein 3) regulates circadian clock-dependent AS by binding to exons at coding sequences flanking exons that are more frequently skipped in clock mutant β cells, including transcripts encoding Cask (calcium/calmodulin-dependent serine protein kinase) and Madd (MAP kinase-activating death domain).
    [Show full text]
  • The Unique Brucella Effectors Nyxa and Nyxb Target SENP3 to Modulate the Subcellular Localisation of Nucleolar Proteins
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.23.441069; this version posted April 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The unique Brucella effectors NyxA and NyxB target SENP3 to modulate the subcellular localisation of nucleolar proteins Artur Louche1, Amandine Blanco1, Thais Lourdes Santos Lacerda1, Claire Lionnet2, Célia Bergé1, Monica Rolando3, Frédérique Lembo4, Jean-Paul Borg4,5, Carmen Buchrieser3, Masami Nagahama6, Jean-Pierre Gorvel7, Virginie Gueguen-Chaignon8, Laurent Terradot1, , and Suzana P. Salcedo1, 1Laboratory of Molecular Microbiology and Structural Biochemistry, Centre National de la Recherche Scientifique UMR5086, Université de Lyon, Lyon, France 2Laboratoire de Reproduction et Developpement des Plantes, Universite de Lyon, ENS de Lyon, UCBL, INRA, CNRS, Lyon, France 3Institut Pasteur, Biologie des Bactéries Intracellulaires, CNRS UMR 3525, Paris, France 4Aix-Marseille Université, Inserm, Institut Paoli-Calmettes, CNRS, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France 5Institut Universitaire de France 6Laboratory of Molecular and Cellular Biochemistry, Meiji Pharmaceutical University, Tokyo, Japan 7Aix-Marseille Univ, CNRS, INSERM, CIML, Marseille, France 8Protein Science Facility, SFR Biosciences, Centre National de la Recherche Scientifique UAR3444, Université de Lyon, Lyon, France The cell nucleus is a primary target for intracellular bacterial SENP3 functions as a processing enzyme for the SUMO2/3 pathogens to counteract immune responses and hijack host sig- precursor and as a deconjugase of SUMOylated substrates. nalling pathways to cause disease.
    [Show full text]